We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VIVT3:BMFBOVESPATelefonica Brasil S.A. Analysis

Data as of 2026-03-11 - not real-time

R$41.53

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Telefônica Brasil (VIVT3) is trading at BRL 41.53, just below its 20‑day SMA (BRL 41.67) but comfortably above the 50‑day (BRL 37.76) and 200‑day (BRL 33.85) averages, indicating a short‑term pull‑back within a longer‑term bullish framework. The stock sits above the calculated support of BRL 39.23 and under the resistance ceiling of BRL 43.47, while the RSI of 56.9 points to neutral momentum. However, the MACD histogram is negative and the signal line is flagged “bearish,” suggesting caution on any upside burst in the near term.
Fundamentally, VIVT3 posted 7.1% revenue growth YoY, maintains a solid operating margin of 19.5% and a free‑cash‑flow conversion of roughly 50%, supporting a generous 5.34% dividend yield with a 53% payout ratio. The forward PE of 12.7 is well below the current PE of 21.7 and the industry average of 18.2, and the DCF‑derived fair value of BRL 56.2 implies modest upside, though the computed upside/downside metric shows a slight premium to fair value. Low beta (≈0.04) and stable volume further temper market risk, while moderate 30‑day volatility (≈24%) and Brazil‑specific regulatory exposure define the primary risk backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at BRL 43.47
  • Bearish MACD divergence
  • High dividend yield provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 7.1% and expanding operating margin
  • Forward PE of 12.7 versus industry average
  • DCF fair value suggests upside potential

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable 5.34% dividend yield
  • Low beta indicating defensive profile
  • Strong cash generation supporting future investments

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin10.35%
P/E Ratio21.7
ROE8.90%
ROA5.24%
Debt/Equity29.63
P/B Ratio1.9
Op. Cash FlowR$20.7B
Free Cash FlowR$10.2B
Industry P/E18.2

Technical Analysis

TrendBullish
RSI56.9
SupportR$39.23
ResistanceR$43.47
MA 20R$41.67
MA 50R$37.76
MA 200R$33.85
MACDBearish
VolumeStable
Fear & Greed Index76.25

Valuation

Fair ValueR$56.17
Target PriceR$38.99
Upside/Downside-6.13%
GradeFair
TypeBlend
Dividend Yield5.34%

Risk Assessment

Beta0.04
Volatility23.91%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.